New Age Beverages Corp (NBEV)
$1.81 0.04 (2.16%)
19:36 EST NBEV Stock Quote Delayed 15 Minutes
Previous Close $1.81
Market Cap 71.43M
PE Ratio -11.31
Volume (Avg. Vol.) 1.21M
Day's Range 1.80 - 1.88
52-Week Range 1.66 - 7.79
Dividend & Yield N/A (N/A)
NBEV Stock Predictions, Articles, and New Age Beverages Corp News
- From InvestorPlace
- From the Web
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
For anyone that can’t afford to lose money from their portfolio, NBEV stock is highly inappropriate. But for the gambler, a reasonable catalyst does exist.
NBEV stock is intriguing as its revenue is growing and it has a CBD opportunity. But NBEV is failing to deliver on its promise.
At this point NBEV stock looks like a falling knife with very little upside potential.
So far in 2019, Willis has sold NBEV stock on seven occasions: April 5, April 9, June 17, July 15, August 15, September 16, and October 15. In total, Willis has sold 425,000 shares this year at prices between $2.73 in October and $5.97 in April. Assuming an average sale price of $3.75, Willis netted $1.6 million before tax.
New Age Beverages stock is a multi-level marketing loser. The CEO is selling shares and the company is in debt and losing money.
NBEV stock could rise by seven-fold from here, but it's far more likely that shares remain weak thanks to glaring profitability issues.
The Federal Reserve is in focus and so are software and cloud stocks. Here's what happened in the stock market today.
Cannabis stocks were torched Thursday, while trade talks continue. Here's what happened in the stock market today.
New Age Beverages is the real deal, but a disconnect between it and NBEV stock ended up punishing many unsuspecting investors.
While cannabis investments like Cronos Group stock have done well earlier in the game, this sector has lost significant credibility. As such, you don’t want to spend too much money on CRON, which is both technically and fundamentally weak.
As a rule, lower-priced stocks are priced that way for a reason. Still, that doesn’t mean you can’t turn a profit trading short, as well as long, in Nio stock and NBEV.
The outlook on New Age Beverages is simple. NBEV stock could rise by 400% over the next five years... or end up as a penny stock.
Each one of these five small-cap stocks has the potential to take off and achieve multi-bagger status over the next five years.
NBEV stock could be a contrarian play amid the vaping crisis as New Age Beverages makes more-acceptable CBD-infused drinks.
Hexo stock is too dangerous to deal with right now, even though the company is doing everything it's supposed to be doing at a manageable pace.
Like other cannabis investments, Aurora Cannabis stock has suffered incredible volatility recently. In order to generate some confidence, ACB stock must start justifying its rich premium.
NBEV stock is a potential multi-bagger in the long run... but the pathway to 100%-plus returns lacks visibility and tangibility.
From Seeking Alpha
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader